ZimVie Inc. (ZIMV)

Market Cap	274.75M
Revenue (ttm)	443.55M
Net Income (ttm)	-19.54M
Shares Out	27.92M
EPS (ttm)	-0.71
PE Ratio	n/a
Forward PE	11.72
Dividend	n/a
Ex-Dividend Date	n/a

Volume	180,577
Open	9.33
Previous Close	9.35
Day's Range	9.22 - 10.00
52-Week Range	8.15 - 22.40
Beta	1.97
Analysts	Hold
Price Target	10.00 (+1.42%)
Earnings Date	Jul 31, 2025

About ZIMV

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. The company offers dental implant systems and biomaterials; digital dentistry solutions; restorative and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2021
• Employees: 1,770
• Stock Exchange: NASDAQ
• Ticker Symbol: ZIMV
• Website: https://www.zimvie.com

Financial Performance

In 2024, ZimVie's revenue was $449.75 million, a decrease of -1.68% compared to the previous year's $457.43 million. Losses were -$25.83 million, -93.43% less than in 2023.

Analyst Summary

According to 2 analysts, the average rating for ZIMV stock is "Hold." The 12-month stock price target is $10.0, which is an increase of 1.42% from the latest price.

Price Target

$10.0

(1.42% upside)

Analyst Consensus: Hold